The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosis
Abstract
Objective: Studies investigating the impact of comorbid substance use disorders (SUD) in psychosis have tended to focus on cross‐sectional data, with few studies examining the effects of substance use course on clinical outcome. The main aim of the present study was to assess the impact of baseline SUD and course of SUD on remission of positive symptoms. Method: The Early Psychosis Prevention and Intervention Centre admitted 786 first‐episode psychosis (FEP) patients between 1998 and 2000. Data on SUD and clinical outcome were collected from patients’ medical records (MR) of 643 patients who met inclusion criteria. Results: Lifetime prevalence of SUD was 74%, with 62% having a SUD at baseline. This reduced to 36% in those patients who completed 18 months of treatment at the EPPIC program. A Cox regression analysis indicated that a decrease or cessation of substance use significantly increased the probability of remission, whilst persistent SUD substantially reduced the likelihood. In addition, patients who reduced use appeared to have better outcomes at 18 months than those patients who had never used substances. Baseline SUD was not found to have any significant influence on symptom remission. Conclusion: Patients presenting with FEP have high rates of SUD. Effective management of psychosis within a specialized service is associated with reductions in SUD over the course of treatment, although persistent substance use is associated with non‐compliance, treatment drop‐out and poor remission rates. As such, young people with FEP and comorbid substance use should be offered integrated treatment that addresses both disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
EPPIC: An Evolving System of Early Detection and Optimal Management
McGorry, P. D., Edwards, J., Mihalopoulos, C., Harrigan, S. M., & Jackson, H. J. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.305 · Cited by 937
Self-citationCannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
Medication noncompliance and substance abuse among patients with schizophrenia
(1996) · Psychiatric Services · doi:10.1176/ps.47.8.853 · Cited by 330
Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden
Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00114-6 · Cited by 261 · cited 2×
“In terms of course and outcome, SUD have been associated with poorer medication adherence (4, 18, 19), higher rates of relapse (19, 20), poorer treatment response (4, 8), higher rates of suicide attempts (21, 22), and LambertM, Conus P, LubmanDI,WadeD, YuenH,Moritz S, Naber D, McGorry PD, Schimmelmann BG.”
BackgroundSubstance use: a powerful predictor of relapse in schizophrenia
Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00068-2 · Cited by 247
Substance use disorders in schizophrenia: review, integration, and a proposed model
Blanchard, J. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00033-1 · Cited by 240
Implementing Early Intervention in Psychosis: A Guide to Establishing Psychosis Services
Edwards, J., & McGorry, P. D. (2002) · doi:10.1201/b14315 · Cited by 226
Self-citationComorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment
Arndt, S., Tyrrell, G., Flaum, M., & Andreasen, N. C. (1992) · Psychological Medicine · doi:10.1017/s0033291700030324 · Cited by 189
Kavanagh, D. J., Waghorn, G., Jenner, L., Chant, D. C., Carr, V., Evans, M., Herrman, H., Jablensky, A., & McGrath, J. J. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00130-0 · Cited by 184
Substance misuse at presentation to an early psychosis program
Van Mastrigt, S., Addington, J., & Addington, D. (2004) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-004-0713-0 · Cited by 179
Salyers, M. P., & Mueser, K. T. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00063-3 · Cited by 167
Gossop, M., Marsden, J., Stewart, D., Lehmann, P., Edwards, C., Wilson, A., & Segar, G. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.2.166 · Cited by 165
Sevy, S. M., Robinson, D. G., Holloway, S., Alvir, J., Woerner, M. G., Bilder, R. M., GOLDMAN, R. S., Lieberman, J. A., & Kane, J. M. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00452.x · Cited by 157
Rabinowitz, J., Bromet, E. J., Lavelle, J., Carlson, G. A., Kovasznay, B. M., & Schwartz, J. E. (1998) · Psychological Medicine · doi:10.1017/s0033291798007399 · Cited by 138
Royal Park Multidiagnostic Instrument for Psychosis: Part II. Development, Reliability, and Validity
McGorry, P. D., SINGH, B. S., Copolov, D., Kaplan, I., Dossetor, C. R., & van Riel, R. J. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.517 · Cited by 133
Self-citationA brief motivational intervention for substance misuse in recent-onset psychosis
KAVANAGH, D. J., YOUNG, R., WHITE, A., SAUNDERS, J. B., WALLIS, J., SHOCKLEY, N., JENNER, L., & CLAIR, A. (2004) · Drug and Alcohol Review · doi:10.1080/09595230410001704127 · Cited by 121
Effect of substance misuse in early psychosis
Addington, J., & Addington, D. E. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297791 · Cited by 121
Royal Park Multidiagnostic Instrument for Psychosis: Part I. Rationale and Review
McGorry, P. D., Copolov, D., & SINGH, B. S. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.501 · Cited by 121
Self-citationComorbid non-alcohol substance misuse among people with schizophrenia
Duke, P. J., Pantelis, C., McPhillips, M. A., & Barnes, T. R. E. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.6.509 · Cited by 111
Patterns of substance abuse in Schizophrenia: Nature and significance
DeQuardo, J. R., Carpenter, C. F., & Tandon, R. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90010-8 · Cited by 108
Motivational interviewing among psychiatric in‐patients with substance use disorders
Baker, A., Lewin, T. J., Reichler, H., Clancy, R., Carr, V. J., Garrett, R., Sly, K. A., Devir, H., & Terry, M. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.01118.x · Cited by 100
Kamali, M., Kelly, L., Gervin, M., Browne, S., Larkin, C., & O'Callaghan, E. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101006452.x · Cited by 98
Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects
Sorbara, F., Liraud, F., Assens, F., Abalan, F., & Verdoux, H. (2003) · European Psychiatry · doi:10.1016/s0924-9338(03)00027-0 · Cited by 96
Past substance abuse and clinical course of schizophrenia
Zisook, S., Heaton, R. K., Moranville, J., Kuck, J., Jernigan, T. L., & BRAFF, D. L. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.4.552 · Cited by 95
Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia.
Mueser, K. T., Drake, R. E., Ackerson, T. H., Alterman, A. I., Miles, K. M., & Noordsy, D. L. (1997) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.106.3.473 · Cited by 93
Clinical Aspects of Substance Abuse in Persons with Schizophrenia
Negrete, J. C. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800104 · Cited by 59
Rosenthal, R. N., Hellerstein, D. J., & Miner, C. R. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90052-j · Cited by 30
Changing Patterns of Illicit Substance Use Among Schizophrenic Patients: 1984–1996
Patkar, A. A., Alexander, R., Lundy, A. C., & Certa, K. (1999) · American Journal on Addictions · doi:10.1080/105504999306090 · Cited by 21
Substance misuse in patients with schizophrenia: a primary care guide
Lubman, D. I., & Sundram, S. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05312.x · Cited by 21
Self-citation
Cited by
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 482
Substance use in a population-based clinic sample of people with first-episode psychosis
Barnett, J. H., Werners, U., Secher, S. M., Hill, K. E., Brazil, R., Masson, K., Pernet, D. E., Kirkbride, J. B., Murray, G. K., Bullmore, E. T., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.024448 · Cited by 271
Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., Conus, P., Takagi, M. J., Fornito, A., Wood, S. J., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq079 · Cited by 255
Self-citationPsychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study
Hides, L., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.014308 · Cited by 166
Outcomes for 236 patients from a 2‐year early intervention in psychosis service
Turner, M. A., Boden, J. M., Smith‐Hamel, C., & Mulder, R. T. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01386.x · Cited by 66
Metadata
- Authors
- Lambert, M., Conus, P., Lubman, D. I., Wade, D., Yuen, H., Moritz, S., Naber, D., McGorry, P. D., & Schimmelmann, B. G.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2005-04-26
- Volume
- 112
- Issue
- 2
- Pages
- 141-148
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2030496540
- Cited by
- 349
- References
- 30
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.